1-2 of 2
Federico Erbella
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib Alone or in Combination with R-CHOP Chemoimmunotherapy in Relapsed or Refractory Primary Central Nervous System Lymphoma (rrPCNSL): A «Real-Life» Study

Teresa Calimeri, Federico Erbella, Lorella Orsucci, Teresa Aloisi, Annalisa Arcari, Cirino Botta, Annarosa Cuccaro, Pio Manlio Mirko Frascione, Stefania Girlanda, Manuel Gotti, Sabrina Mariani, Luca Nassi, Fioravante Ronconi, Luana Schiattone, Alessandra Tucci, Luisa Verga, Vincenzo Mercurio, Paolo Fiore, Sara Steffanoni, Fabio Ciceri, Andrés J.M. Ferreri
Journal: Blood
Blood (2022) 140 (Supplement 1): 6678–6680.
https://doi.org/10.1182/blood-2022-170143
Published: 2022
Journal Articles

Late Failure of Aggressive B-Cell Lymphoma Following CAR T-Cell Therapy: A Lysa Study from the Descar-T Registry

Federico Erbella, Emmanuel Bachy, Guillaume Cartron, Elodie Gat, Franck Morschhauser, Benoit Tessoulin, Olivier Tournilhac, Choquet Sylvain, François-Xavier Gros, Cristina Castilla-Llorente, Arnaud Campidelli, René-Olivier Casasnovas, Louise Roulin, Pierre Bories, Mohamad Mohty, Martin Carre, Steven Le Gouill, Roch Houot, Roberta Di Blasi
Journal: Blood
Blood (2022) 140 (Supplement 1): 1325–1327.
https://doi.org/10.1182/blood-2022-165352
Published: 2022